A clinical study indicated that selenium supplementation in selenium-deficient populations could enhance GPX4 activity, inhibit ferroptosis in intestinal epithelial cells, and repair intestinal epithelial barrier function, thereby preventing the onset of IBD [23]. This evidence concerns the gene GPX4 and inflammatory bowel disease.